Search
Caris Life Sciences Inc
CAIAdd to Watchlist
18.470USD
+0.610+3.42%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
5.05BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Caris Life Sciences Inc is 8.67, ranking 17 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 39.00, with a high of 45.00 and a low of 28.00.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
28.333
Target Price
+55.85%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Caris Life Sciences Inc
CAI
12
Medtronic PLC
MDT
33
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Caris Life Sciences Inc's expected revenue for the next quarter?
Caris Life Sciences Inc's expected revenue is 238.30M.
What is Caris Life Sciences Inc's price target?
Analysts forecast that Caris Life Sciences Inc's price target is USD 39.00, with the highest forecast at USD 45.00 and the lowest forecast at USD 28.00.
How have Caris Life Sciences IncCAI's recent earnings per share performed?
The market expectation was USD -0.00, while Caris Life Sciences IncCAI's earnings per share (EPS) for the previous quarter was USD 0.29. EPS for the next quarter is expected at USD 0.01.
What is the analyst rating for Caris Life Sciences Inc?
Based on the ratings of Caris Life Sciences Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
